SPG20 Antikörper (Middle Region)

Produktnummer ABIN2786078

Produktdetails anti-SPG20 Antikörper

Target: SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Bindungsspezifität: Middle Region

Reaktivität: Human, Maus, Ratte, Pferd, Rind (Kuh), Hund, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio)

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SPG20 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Sequenz: ASWVSWGLVK GAEITGKAIQ KGASKLRERI QPEEKPVEVS PAVTKGLYIA

Homologie: Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 79%

Produktmerkmale: This is a rabbit polyclonal antibody against SPG20. It was validated on Western Blot using a cell lysate as a positive control.

Aufreinigung: Affinity Purified

Immunogen: The immunogen is a synthetic peptide directed towards the middle region of human SPG20

Anwendungsinformationen

Applikationshinweise: Optimal working dilutions should be determined experimentally by the investigator.

Kommentare:

Antigen size: 666 AA

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Details zu SPG20

Target: SPG20 (Spastic Paraplegia 20 (Troyer Syndrome) (SPG20))

Andere Bezeichnung: SPG20 (SPG20 Produkte)

Synonyme: SPARTIN antikoerper, TAHCCP1 antikoerper, AI840044 antikoerper, C79168 antikoerper, mKIAA0610 antikoerper, spartin antikoerper, Spg20 antikoerper, spg20a antikoerper, zgc:172059 antikoerper, spg20b antikoerper, zgc:153766 antikoerper, spartin antikoerper, spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) antikoerper, spartin a antikoerper, spartin b antikoerper, SPART antikoerper, Spg20 antikoerper, Spart antikoerper, sparta antikoerper, spartb antikoerper

Hintergrund: This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome).
Alias Symbols: KIAA0610, SPARTIN, TAHCCP1
Protein Interaction Partner: UBC, WWOX, ITCH, PLIN3, SMURF2, ZFYVE9, APP, EPS15, SMURF1, WWP2, WWP1, SUMO2, KLC2, AIFM1, VIM, NCL, LMNB1, KPNB1, KIF5B, HSPD1, HSPA9, HSPA5, HADHA, ACSL4, ACSL3, DYNC1H1, COPA, CLTC, TUBA1A,
Protein Size: 666

Molekulargewicht: 73 kDa

Gen-ID: 23111

NCBI Accession: NM_015087, NP_055902

UniProt: Q8N0X7

Pathways: Regulation of Cell Size, SARS-CoV-2 Protein Interaktom